We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$262M
AUM Growth
-$290K
Cap. Flow
-$14M
Cap. Flow %
-5.35%
Top 10 Hldgs %
74.48%
Holding
143
New
12
Increased
13
Reduced
10
Closed
30

Top Buys

Rank Stock Value
1
CLOZ icon
Panagram BBB-B CLO ETF
CLOZ
+$15.7M
2
ICLO icon
Invesco AAA CLO Floating Rate Note ETF
ICLO
+$5.87M
3
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$3.12M
4
SNY icon
Sanofi
SNY
+$2.3M
5
CLOX icon
Panagram AAA CLO ETF
CLOX
+$1.96M

Top Sells

Rank Stock Value
1
MDWT
Midwest Holding Inc. Common Stock
MDWT
+$10.2M
2
MITAW
Coliseum Acquisition Corp. Warrant
MITAW
+$5.69M
3
FBRT
Franklin BSP Realty Trust
FBRT
+$4.34M
4
CLMT icon
Calumet Specialty Products
CLMT
+$4.07M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$3.82M

Sector Composition

Rank Sector Weight
1 Materials 30.32%
2 Healthcare 27.8%
3 Financials 10.28%
4 Industrials 8.49%
5 Communication Services 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AB icon
26
AllianceBernstein
AB
$3.54B
$1.52M 0.58%
49,000
-500
-1% -$14.7K
RHP icon
27
Ryman Hospitality Properties
RHP
$7.99B
$1.32M 0.5%
12,000
– –
VRTX icon
28
Vertex Pharmaceuticals
VRTX
$123B
$1.22M 0.47%
3,000
– –
PTGX icon
29
Protagonist Therapeutics
PTGX
$9.06B
$1.2M 0.46%
52,368
– –
XENE icon
30
Xenon Pharmaceuticals
XENE
$6.6B
$1.1M 0.42%
23,866
– –
MDLZ icon
31
Mondelez International
MDLZ
$78.3B
$1.01M 0.39%
14,000
– –
ABEO icon
32
Abeona Therapeutics
ABEO
$399M
$993K 0.38%
198,300
+38,300
+24% +$168K
XERS icon
33
Xeris Biopharma Holdings
XERS
$1.52B
$912K 0.35%
+387,910
New +$716K
ABBV icon
34
AbbVie
ABBV
$450B
$781K 0.3%
5,037
– –
EOLS icon
35
Evolus
EOLS
$377M
$769K 0.29%
73,066
+5,000
+7% +$44.7K
DD icon
36
DuPont de Nemours
DD
$18.3B
$764K 0.29%
7,911
– –
KMB icon
37
Kimberly-Clark
KMB
$36B
$729K 0.28%
6,000
– –
VRNA
38
DELISTED
Verona Pharma
VRNA
$650K 0.25%
+32,672
New +$482K
SYRS
39
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$623K 0.24%
79,927
-26,048
-25% -$89.2K
DOW icon
40
Dow Inc
DOW
$21.6B
$611K 0.23%
11,136
– –
MSFT icon
41
Microsoft
MSFT
$2.93T
$602K 0.23%
1,600
– –
CTVA icon
42
Corteva
CTVA
$58.4B
$554K 0.21%
11,563
– –
CNQ icon
43
Canadian Natural Resources
CNQ
$91.5B
$550K 0.21%
16,800
– –
MCRB icon
44
Seres Therapeutics
MCRB
$51.6M
$519K 0.2%
18,537
+15,037
+430% +$395K
BBIO icon
45
BridgeBio Pharma
BBIO
$15.9B
$484K 0.19%
12,000
+3,000
+33% +$90.1K
AAPL icon
46
Apple
AAPL
$4.9T
$480K 0.18%
2,494
– –
KO icon
47
Coca-Cola
KO
$351B
$448K 0.17%
7,600
– –
ROIV icon
48
Roivant Sciences
ROIV
$24.8B
$418K 0.16%
+37,200
New +$363K
XOMA
49
DELISTED
Xoma
XOMA
$365K 0.14%
19,722
– –
IBM icon
50
IBM
IBM
$200B
$350K 0.13%
2,142
– –
1
2
3 4 5

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
TT
TI-Trust Quincy, Illinois $168M AUM 24.32% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return

David M. Knott Jr's Q4 2023 Portfolio in Review

As of Q4 2023, David M. Knott Jr held 143 positions worth $262M, down 0.11% from $262M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

David M. Knott Jr withdrew a net $14M in Q4 2023, closing 30 positions and reducing 10 holdings. Its most notable exit was Midwest Holding Inc. Common Stock, an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Materials at 30% of assets, down from 35% a quarter earlier, followed by Healthcare and Financials.

Against the trend, David M. Knott Jr opened a new position in Sanofi worth $2.34M.

  • David M. Knott Jr's largest Q4 2023 buy was Sanofi: 47,000 shares worth $2.34M.
  • David M. Knott Jr added most to Panagram BBB-B CLO ETF in Q4 2023, an estimated $15.7M increase.
  • David M. Knott Jr's biggest Q4 2023 reduction was Calumet Specialty Products, cutting an estimated $4.07M.
  • David M. Knott Jr fully exited Midwest Holding Inc. Common Stock in Q4 2023, selling an estimated $10.2M.
  • David M. Knott Jr's ten largest holdings make up 74% of its $262M portfolio in Q4 2023.
  • David M. Knott Jr opened 12 new positions and closed 30 in Q4 2023.
  • David M. Knott Jr's portfolio value fell 0.11% quarter-over-quarter to $262M.

Based on David M. Knott Jr's 13F filing for Q4 2023, filed 13 Feb 2024.